CastaƱares, Ethel Jane .
HRN: 22-25-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
CEFUROXIME 1.5GM (VIAL)
11/25/2025
11/27/2025
IV
1.5gm
Q8hr X 2 Doses
Sp LTCS With BTL
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes